HAMP and type 2 diabetes mellitus: For example in Activin-B deficient mice LPS treatment stimulated hepcidin expression without activation of the SMAD pathway [35] and in a mouse model of type 2 diabetes the activation of the BMP/SMAD pathway was associated with hepcidin mRNA downregulation [36].